- Supported exchanges /
- F /
- 4LN2.F
CAPRICOR THERAP. DL-001 (4LN2 F) stock market data APIs
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment of duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase 3 clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD). It also focused on developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases. In addition, the company develops CAP-2003, under pre-clinical development for the treatment of trauma related injuries and conditions. It has collaboration and distribution agreement with Nippon Shinyaku Co. Ltd., collaboration agreement with National Institute of Allergy and Infectious Diseases, license agreements with the Johns Hopkins University and Cedars-Sinai Medical Center, as well as cell line license agreement with Life Technologies Corporation. The company was founded in 2005 and is headquartered in San Diego, California.
CAPRICOR THERAP. DL-001 Financial Data Overview
| 19.12 | |
| 19.22 | |
| - | |
| 19.22 | |
| 18.76 | |
| 2.54-20.45 | |
| 920 M | |
| 45 406 K | |
| 27 152 K | |
| -0.21 | |
| 4.029 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
CAPRICOR THERAP. DL-001 Fundamental Data is available in our Financial Data APIs
- Net Revenue 27 152 K
- EBITDA -28 730 592
- Earnings Per Share -0.82
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get CAPRICOR THERAP. DL-001 Earnings via APIs
- Latest Release 2021-06-30
- EPS/Forecast -0.23
Get CAPRICOR THERAP. DL-001 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
